Kimberly Manhard

Director/Board Member bei INHIBRX, INC.

Vermögen: 66 294 $ am 31.03.2024

64 Jahre

Health Technology

Consumer Services

Aktive Positionen von Kimberly Manhard

Unternehmen	Position	Beginn	Ende
INHIBRX, INC.	Director/Board Member	01.06.2020	-
INHIBRX, INC.	Independent Dir/Board Member	01.06.2020	-
ACADIA PHARMACEUTICALS INC.	Corporate Officer/Principal	30.01.2024	-
Fleet Science Center	Director/Board Member	-	-
Shoreline Biosciences, Inc. Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA.	Director/Board Member	19.05.2021	-
Toragen, Inc. Toragen, Inc. BiotechnologyHealth Technology Toragen, Inc. is a clinical-stage biotechnology company that is focused on developing treatments for HPV-induced cancers, starting with head and neck cancer. Toragen is based in San Diego, CA. The company is targeting the root cause of virally induced cancers. The company was founded by Andrew Sharabi and the CEO is Sandra I. Coufal.	Director/Board Member	01.05.2020	-

Unternehmen	Position	Beginn	Ende
HERON THERAPEUTICS, INC.	Director/Board Member	01.10.2019	21.02.2023
	Independent Dir/Board Member	13.01.2014	28.01.2016
	Corporate Officer/Principal	28.01.2016	06.06.2023
Ardea Biosciences, Inc. Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE.	Director/Board Member	19.06.2009	01.01.2016
	Compliance Officer	19.06.2009	01.01.2016
	Chief Operating Officer	01.01.2008	23.06.2009
	General Counsel	01.01.2008	11.06.2015
EXELIXIS, INC.	General Counsel	01.01.2002	01.01.2003
G.H. Besselaar Associates	Corporate Officer/Principal	-	-
░░░ ░░░░░ ░░░ ░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-	-
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░	░░░░░░░ ░░░░░░░	-	-
░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░	░░░░░░░ ░░░░░░░	░░░░░░░░░░	-

University of Florida

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Director/Board Member	6
General Counsel	4
Corporate Officer/Principal	4

Sektoral

Health Technology	10
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	6
HERON THERAPEUTICS, INC.	Health Technology
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
ELI LILLY AND COMPANY	Health Technology
EXELIXIS, INC.	Health Technology
ACADIA PHARMACEUTICALS INC.	Health Technology
INHIBRX, INC.	Health Technology

Private Unternehmen	6
Ardea Biosciences, Inc. Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE.	Health Technology
Agouron Global Commercial Operations
G.H. Besselaar Associates
Shoreline Biosciences, Inc. Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA.	Health Technology
Fleet Science Center
Toragen, Inc. Toragen, Inc. BiotechnologyHealth Technology Toragen, Inc. is a clinical-stage biotechnology company that is focused on developing treatments for HPV-induced cancers, starting with head and neck cancer. Toragen is based in San Diego, CA. The company is targeting the root cause of virally induced cancers. The company was founded by Andrew Sharabi and the CEO is Sandra I. Coufal.	Health Technology